Gene · 79679
Papers2,409
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,101 to 1,120 of 2,409
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Association analysis of B7-H3 and B7-H4 gene single nucleotide polymorphisms in susceptibility to ankylosing spondylitis in eastern Chinese Han population. | Int J Immunogenet | 2021 | 34555253 | PubTator, text mining | PubMed |
| Predicting the Survival and Immune Landscape of Colorectal Cancer Patients Using an Immune-Related lncRNA Pair Model. | Front Genet | 2021 | 34552614 | PubTator, text mining | PubMed |
| The immunotherapy candidate TNFSF4 may help the induction of a promising immunological response in breast carcinomas. | Sci Rep | 2021 | 34545132 | PubTator, text mining | PubMed |
| Profiling the inhibitory receptors LAG-3, TIM-3, and TIGIT in renal cell carcinoma reveals malignancy. | Nat Commun | 2021 | 34545095 | PubTator, text mining | PubMed |
| MAPK-pathway inhibition mediates inflammatory reprogramming and sensitizes tumors to targeted activation of innate immunity sensor RIG-I. | Nat Commun | 2021 | 34535668 | PubTator, text mining | PubMed |
| Soluble B7-CD28 Family Inhibitory Immune Checkpoint Proteins and Anti-Cancer Immunotherapy. | Front Immunol | 2021 | 34531847 | PubTator, text mining | PubMed |
| circHMGCS1-016 reshapes immune environment by sponging miR-1236-3p to regulate CD73 and GAL-8 expression in intrahepatic cholangiocarcinoma. | J Exp Clin Cancer Res | 2021 | 34526098 | PubTator, text mining | PubMed |
| Identification of metabolism-associated molecular subtype in ovarian cancer. | J Cell Mol Med | 2021 | 34523782 | PubTator, text mining | PubMed |
| Comprehensive analysis of angiogenesis subtype of squamous cell carcinoma. | World J Surg Oncol | 2021 | 34521431 | PubTator, text mining | PubMed |
| Deconvolution of multiplexed transcriptional responses to wood smoke particles defines rapid aryl hydrocarbon receptor signaling dynamics. | J Biol Chem | 2021 | 34520756 | PubTator, text mining | PubMed |
| Molecular and Clinical Characterization of LIGHT/TNFSF14 Expression at Transcriptional Level via 998 Samples With Brain Glioma. | Front Mol Biosci | 2021 | 34513918 | PubTator, text mining | PubMed |
| A Prognostic Signature Constructed by CTHRC1 and LRFN4 in Stomach Adenocarcinoma. | Front Genet | 2021 | 34512711 | PubTator, text mining | PubMed |
| Mammary-specific expression of Trim24 establishes a mouse model of human metaplastic breast cancer. | Nat Commun | 2021 | 34508101 | PubTator, text mining | PubMed |
| The value of comprehensive genomic sequencing to maximize the identification of clinically actionable alterations in advanced cancer patients: a case series. | Oncotarget | 2021 | 34504655 | PubTator, text mining | PubMed |
| Malignant Ascites in Ovarian Cancer: Cellular, Acellular, and Biophysical Determinants of Molecular Characteristics and Therapy Response. | Cancers (Basel) | 2021 | 34503128 | PubTator, text mining | PubMed |
| A single-cell and spatially resolved atlas of human breast cancers. | Nat Genet | 2021 | 34493872 | PubTator, text mining | PubMed |
| The Therapeutic Potential of Mesenchymal Stromal Cells for Regenerative Medicine: Current Knowledge and Future Understandings. | Front Cell Dev Biol | 2021 | 34490235 | PubTator, text mining | PubMed |
| Pan-Tissue Aging Clock Genes That Have Intimate Connections with the Immune System and Age-Related Disease. | Rejuvenation Res | 2021 | 34486398 | PubTator, text mining | PubMed |
| Poor Prognosis and Therapeutic Responses in LILRB1-Expressing M2 Macrophages-Enriched Gastric Cancer Patients. | Front Oncol | 2021 | 34485116 | PubTator, text mining | PubMed |
| B7 homologue 3 as a prognostic biomarker and potential therapeutic target in gastrointestinal tumors. | World J Gastrointest Oncol | 2021 | 34457187 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/79679/papers?page=56